JPRN-jRCTs052230123招募中2 期
An Exploratory Clinical Study on the Efficacy and Safety of Coolief Cooling Radiofrequency Therapy for Chronic Pain after Total Knee Arthroplasty
Matsumoto Tomoyuki0 个研究点目标入组 6 人开始时间: 2023年11月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •(1) Patients with chronic pain lasting more than 6 months in the knee joint after TKA surgery.
- •(2) Patients must be at least 18 years of age, regardless of gender.
- •(3) Patients who have had unsatisfactory results with existing pain relief therapies (Existing pain relief therapy here refers to NSAIDs, steroids, oral opioids, pregabalin, etc.).
- •(4) Patients with at least a 50% reduction in NRS for knee nerve blocks (superior medial, superior lateral, and inferior medial knee nerve).
- •(5) Patients who have given their free and voluntary written consent to participate in this clinical study.
排除标准
- •(1) Patients with inflammation, etc. (pyogenic arthritis, gout, pseudogout) in the knee joint.
- •(2) Patients with systemic infection.
- •(3) Patients with neurological pre-existing conditions (diabetic peripheral neuropathy, spondylolisthesis, or spinal fistula).
- •(4) Patients with blood coagulation disorders or using anticoagulants.
- •(5) Patients already receiving CRFA treatment for knee osteoarthritis.
- •(6) Patients using a pacemaker implantable cardioverter-defibrillator, etc.
- •(7) Other patients deemed inappropriate by the investigators in charge of this clinical study.
研究者
相似试验
已完成
2 期
A study to determine the efficacy and safety of using remimazolam for dental procedures under sedation.JPRN-jRCTs061220052Kana Oue30
招募中
1 期
Exploratory Clinical Study on the Effectiveness of Glycyrrhizin in Early Vascular Lesions of Systemic SclerosisSystemic SclerosisJPRN-UMIN000032238The University of Tokyo20
招募中
不适用
The Effectiveness of Glycyrrhizin in Systemic SclerosisSystemic sclerosisJPRN-jRCTs031180366Sumida Hayakazu20
已完成
2 期
Clinical study to investigate the efficacy and the safety of R-FM for recurrent or refractory indolent B-cell lymphoma - THF016JPRN-UMIN000005442Tohoku Hematology Forum40
招募中
1 期
Clinical Trial for Prevention of Cisplatin-Induced Renal NephrotoxicityCancerJPRN-jRCTs041220021Kondo Masashi21